Evren Alici, MD, PhD: Founder; Chairman & CEO

• Head of Gene & Cell Therapy Group, Division of Hematology, Department of Medicine
  at the Karolinska Institutet (KI) & Karolinska University Hospital, Sweden
• Serves on Advisory Boards for Pfizer, Sanofi and Johnson & Johnson
• Founding Managing Director, NextGenNK at KI

Douglas W. Calder: President & Executive Director

• 25+ Years of Senior Executive Biotech Experience for Public & Private Companies
• Member of Board of Directors for: NextGenNK, Swedish Innovation Agency’s NK Cell Competence
  Center at KI; Zevra Therapeutics (Nasdaq: ZVRA), and BioFlorida

HG Ljunggren, MD, PhD: Founder; Executive Director

• Professor, Former Dean of Research, & Founder of Center for Infectious Medicine at Karolinska Institutet (KI), Sweden
• Founding Managing Director, NextGenNK at KI
• Member of Nobel Assembly at KI

Lara Silverman, PhD: Director of Development & Regulatory Affairs

• Founder, LIS BioConsulting, with Deep Expertise Leading Translational Cell & Gene Therapy Programs Programs
• Key Contributor to Numerous Peer-reviewed Manuscripts & High-impact Presentations
• Frequent Featured Speaker at Key Cell & Gene Therapy Academic and Industry Conferences/Events

Dan Cartwright: Chief Financial Officer

• Seasoned Senior Accounting Professional Leading Public & Private BioPharma Companies including Therapeutics MD
  (Nasdaq: TXMD) & PleoPharma